Related Experiment Video
Updated: May 10, 2026
03:05
Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Autoimmune atrophic gastritis--pathogenesis, pathology and management
William L Neumann1, Elizabeth Coss, Massimo Rugge
1Miraca Life Sciences Research Institute, 6655 North MacArthur Boulevard, Irving, TX 75039, USA.
Nature Reviews. Gastroenterology & Hepatology
|June 19, 2013
Summary
Autoimmune gastritis causes progressive inflammation, leading to vitamin B12 deficiency and pernicious anemia. This review covers its epidemiology, pathogenesis, diagnosis, and management.
Area of Science:
- Gastroenterology
- Immunology
- Pathology
Background:
- Autoimmune gastritis is a chronic inflammatory condition characterized by the destruction of parietal cells.
- This destruction leads to hypochlorhydria, achlorhydria, and impaired vitamin B12 absorption due to autoantibodies against intrinsic factor.
- The resulting cobalamin deficiency manifests as pernicious anemia, with megaloblastic anemia and neurological symptoms.
Purpose of the Study:
- To review the epidemiology, pathogenesis, and pathological features of autoimmune metaplastic atrophic gastritis.
- To provide practical guidance on the diagnosis and management of this condition.
- To highlight the evolving understanding of autoimmune gastritis across diverse populations.
Main Methods:
- Literature review of epidemiological, etiological, and clinical studies.
- Analysis of pathological findings associated with autoimmune gastritis.
- Synthesis of current diagnostic and management strategies.
Main Results:
- Autoimmune gastritis affects all populations, challenging previous assumptions about its prevalence.
- Diagnosis is complex, often complicated by co-infection with Helicobacter pylori.
- The risk of gastric cancer in patients with autoimmune gastritis requires further assessment.
Conclusions:
- Autoimmune gastritis is a complex autoimmune disorder with significant clinical implications, including pernicious anemia.
- Accurate diagnosis and management are crucial, despite diagnostic challenges and potential overlaps with other conditions.
- Further research is needed to fully understand its prevalence and gastric cancer risk.
Related Concept Videos
01:17Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:27Gastritis-I: Introduction and Types
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...